A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.

NCT06133270 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers - Liver Diseases

Interventions

DRUG: NNC0560-0004
DRUG: Placebo (NNC0560-0004)

Sponsor

Novo Nordisk A/S